Shedding Low Yield Testing for Telogen Effluvium: A Cross-Sectional Study of Laboratory Results from Newly Diagnosed Patients
May 2023
in “
Journal of The American Academy of Dermatology
”
New to iron? There is a guide in the encyclopedia. Read the guide → 
Studysummary This correspondence outlines a research aim to evaluate the usefulness of laboratory testing for telogen effluvium to assist in forming evidence-based treatment guidelines, though results are not provided in the abstract.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study examined 16,381 lab results from 1,342 newly diagnosed Telogen effluvium (TE) patients, a common hair loss condition, with an average age of 45.1 years and 92.7% being female. It was found that 81.7% of these patients had no or only mild abnormalities in their lab results. Abnormalities ranged from 2.5% (sodium) to 44% (ANA), with most being mild (72.7%). The study concluded that broad laboratory panels often show no or mild abnormalities in TE patients. Therefore, it suggests that only hemoglobin, ferritin, iron, iron saturation, and TSH tests are most useful in evaluating TE. It also recommends deferring lab testing for TE if there's a clear triggering event, and only ordering the aforementioned tests if there's no known trigger.
